| __timestamp | Iovance Biotherapeutics, Inc. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2704597 | 13673000 |
| Thursday, January 1, 2015 | 15470000 | 14358000 |
| Friday, January 1, 2016 | 28037000 | 12203000 |
| Sunday, January 1, 2017 | 71615000 | 18125000 |
| Monday, January 1, 2018 | 99828000 | 17071000 |
| Tuesday, January 1, 2019 | 166023000 | 20018000 |
| Wednesday, January 1, 2020 | 201727000 | 32788000 |
| Friday, January 1, 2021 | 259039000 | 44966000 |
| Saturday, January 1, 2022 | 294781000 | 311681000 |
| Sunday, January 1, 2023 | 344077000 | 77707000 |
Igniting the spark of knowledge
In the ever-evolving world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Iovance Biotherapeutics, Inc. has consistently outpaced Lantheus Holdings, Inc. in R&D investment. From 2014 to 2023, Iovance's R&D expenses surged by over 12,000%, peaking at approximately $344 million in 2023. In contrast, Lantheus saw a more modest increase, with a peak of around $78 million in the same year.
This trend highlights Iovance's aggressive pursuit of breakthroughs in cancer immunotherapy, while Lantheus focuses on diagnostic imaging. The stark difference in R&D allocation underscores the diverse strategies within the biotech sector, where innovation is the lifeblood of progress. As these companies forge ahead, their R&D investments will continue to shape the future of healthcare.
Eli Lilly and Company vs Lantheus Holdings, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for AstraZeneca PLC and Iovance Biotherapeutics, Inc.
Research and Development: Comparing Key Metrics for Sanofi and Lantheus Holdings, Inc.
R&D Spending Showdown: Zoetis Inc. vs Iovance Biotherapeutics, Inc.
Research and Development Investment: Biogen Inc. vs Iovance Biotherapeutics, Inc.
Research and Development Expenses Breakdown: Sarepta Therapeutics, Inc. vs Lantheus Holdings, Inc.
Blueprint Medicines Corporation or Lantheus Holdings, Inc.: Who Invests More in Innovation?
Research and Development Investment: Lantheus Holdings, Inc. vs Apellis Pharmaceuticals, Inc.
R&D Insights: How Lantheus Holdings, Inc. and Perrigo Company plc Allocate Funds
R&D Spending Showdown: Amicus Therapeutics, Inc. vs Iovance Biotherapeutics, Inc.
Research and Development Investment: Iovance Biotherapeutics, Inc. vs Taro Pharmaceutical Industries Ltd.
Iovance Biotherapeutics, Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?